Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Fatigue 5Breast Neoplasms 5Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Depression 2Congenital Abnormalities 2Carcinoma, Ovarian Epithelial 2Vomiting 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Nausea 1Myeloproliferative Disorders 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Fluorouracil 3Petrolatum 2Cryotherapy 2Aminolevulinic Acid 2tirbanibulin 1Therapeutics 1Sugars 1Solutions 1Retinoids 1Phototherapy 1Photosensitizing Agents 1Photochemotherapy 1Imiquimod 1Celecoxib 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Keratosis, Actinic × Therapeutics × Clear all
NCT00814528 2018-09-10

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

University of Chicago

Phase NA Withdrawn
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡